PCV53 IMPACT OF THE ANTIHYPERTENSIVE AND LIPID-LOWERING TREATMENT TO PREVENT HEART ATTACK TRIAL (ALLHAT) ON PHYSICIAN PRESCRIBING PATTERNS AND PATIENT UTILIZATION OF ANTIHYPERTENSIVE MEDICATIONS
May 1, 2004, 00:00
10.1016/S1098-3015(10)62419-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)62419-9/fulltext
Title :
PCV53 IMPACT OF THE ANTIHYPERTENSIVE AND LIPID-LOWERING TREATMENT TO PREVENT HEART ATTACK TRIAL (ALLHAT) ON PHYSICIAN PRESCRIBING PATTERNS AND PATIENT UTILIZATION OF ANTIHYPERTENSIVE MEDICATIONS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62419-9&doi=10.1016/S1098-3015(10)62419-9
First page :
Section Title :
Open access? :
No
Section Order :
356